Centro de Investigaciones Metabólicas

City of Buenos Aires C1056ABI

0 studies enrolling now · 2 studies all time

What they study most

Chronic Kidney Disease, Diabetes Mellitus, Type 2

Studies at this site

• A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease — Recruiting now
• A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both — Completed